Abstract:Background and Aims This study aimed to report nine Charcot–Marie–Tooth disease (CMT) families with six novel IGHMBP2 mutations in our CMT2 cohort and to summarize the genetic and clinical features of all AR‐CMT2S patients reported worldwide. Methods General information, clinical and neurophysiological data of 275 axonal CMT families were collected. Genetic screening was performed by inherited peripheral neuropathy related genes panel or whole exome sequencing. The published papers reporting AR‐CMT2S from 2014 to 2023 were searched in Pubmed and Wanfang databases. Results In our CMT2 cohort, we detected 17 AR‐CMT2S families carrying IGHMBP2 mutations and eight were published previously. Among these, c.743 T > A (p.Val248Glu), c.884A > G (p.Asp295Gly), c.1256C > A (p.Ser419*), c.2598_2599delGA (p.Lys868Sfs*16), c.1694_1696delATG (p.Asp565del) and c.2509A > T (p.Arg837*) were firstly reported. These patients prominently presented with early‐onset typical axonal neuropathy and without respiratory dysfunction. So far, 56 AR‐CMT2S patients and 57 different mutations coming from 43 families have been reported in the world. Twenty‐nine of 32 missense mutations were clustered in helicase domain and ATPase region. The age at onset ranged from 0.11to 20 years (Mean ± SD: 3.43 ± 3.88 years) and the majority was infantile‐onset (<2 years). The initial symptoms included weakness of limbs (19, 29.7%), delayed milestones (12, 18.8%), gait disturbance (11, 17.2%), feet deformity (8, 12.5%), feet drop (8, 12.5%), etc. Interpretation AR‐CMT2S accounted for 6.2% in our CMT2 cohort. We firstly reported six novel IGHMBP2 mutations which expanded the genotypic spectrum of AR‐CMT2S. Furthermore, 17 AR‐CMT2S families could provide more resources for natural history study, drug research and development.

Infantile‐onset CMT2D/dSMA‐V in a Chinese Family with Parental Germline Mosaicism for a Novel Mutation in the GARS1 Gene

Identification of LAMA2 Compound Heterozygous Variants: a Case Report

[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

A Novel Mutation of LRSAM1 in a Chinese Family with Charcot-Marie-Tooth Disease

A Novel Mutation of the Glycyl-Trna Synthetase (gars) Gene Associated with Charcot-Marie-Tooth Type 2d in A Chinese Family

A Novel Mutation of GARS in a Chinese Family with Distal Hereditary Motor Neuropathy Type V

A Novel TFG C.793c>g Mutation in a Chinese Pedigree with Charcot‐Marie‐Tooth Disease 2

Identification of A Novel SBF2 Frameshift Mutation in Charcot–Marie–Tooth Disease Type 4B2 Using Whole-exome Sequencing

Clinical,pathological and Genetic Studies in a Chinese Charcot-Marie-Tooth Disease Type 2 Family

Case Report: Exome Sequencing Achieved a Definite Diagnosis in a Chinese Family with Muscle Atrophy.

IGHMBP2 -Related Clinical and Genetic Features in a Cohort of Chinese Charcot–Marie–Tooth Disease Type 2 Patients

GARS-related Disease in Infantile Spinal Muscular Atrophy: Implications for Diagnosis and Treatment

Clinical and Mutational Spectrum of Paediatric Charcot-Marie-Tooth Disease in a Large Cohort of Chinese Patients.

Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation

Genotype–phenotype correlations of AR‐CMT2S in a cohort of axonal Charcot–Marie–Tooth patients from Central South China

A Novel P.Va137a1a Mutation In The Gjb1 Gene Of A Chinese Family With X-Linked Recessive Charcot-Marie-Tooth Disease: A Case Report And Literature Review

A familial form of Charcot-Marie-Tooth disease (type 2d) caused by a previously unreported variant in GARS1

Exome Sequencing Reveals a Novel MFN2 Missense Mutation in a Chinese Family with Charcot-Marie-Tooth Type 2A

Case report: A novel mutation of the CAPN3 gene in a Chinese family with limb-girdle muscular dystrophy type 2A

Identification of Two Rare Mutations C.1318g>a and C.6438+2t>g in a Chinese DMD Family As Genetic Markers

A novel splicing mutation in 5'UTR of GJB1 causes X-linked Charcot-Marie-tooth disease